B. Riley Issues Positive Outlook for Novavax Earnings
Novavax, Inc. (NASDAQ:NVAX – Free Report) – Equities research analysts at B. Riley lifted their Q2 2025 earnings estimates for shares of Novavax in a research report issued to clients and investors on Thursday, February 20th. B. Riley analyst M. Mamtani now forecasts that the biopharmaceutical company will earn $0.67 per share for the quarter, […]
Novavax, Inc. (NASDAQ:NVAX – Free Report) – Equities research analysts at B. Riley lifted their Q2 2025 earnings estimates for shares of Novavax in a research report issued to clients and investors on Thursday, February 20th. B. Riley analyst M. Mamtani now forecasts that the biopharmaceutical company will earn $0.67 per share for the quarter, […]
